LFB, a company committed to saving patients
LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products from blood and recombinant proteins for the treatment of patients with serious and often rare diseases.
LFB was founded in 1994 in France and is among the leading European suppliers of blood-derived medicinal products to healthcare professionals. Its vision is to provide patients with new treatment options in three major therapeutic areas: immunology, haemostasis, and intensive care.
LFB is a public company operating in a competitive sector. LFB currently markets 16 medicinal products in more than 30 countries.
Interview with Jacques Brom, CEO of LFB
Major objectives, commitments to patients and employees and industrial challenges: Jacques Brom looks back in video on a year of growth and the mission of LFB employees: their commitment to serve patients.
LFB at a glance
-
2880 employees worldwide in 2023
-
-
